drug · antibody
vilobelimab
Phase 2updated 5mo agoby InflaRx NV🔗 ChEMBL
Phase 2community read0 votes
Antibody drug with a maximum clinical stage of Approval (across all indications), with an approval for adult acute respiratory distress syndrome and 10 investigational indications.
targets
Complement C5
all catalysts(0)
nothing on the calendar yet
Trials studying vilobelimab
- phase2JUST BREATHE, Breathing Life Into Innovative Therapies for ARDS (Master Record)
- phase2JUST BREATHE, Breathing Life Into Innovative Therapies for ARDS- Cohort A: Vilobelimab
- phase3Phase III Trial to Investigate Efficacy and Safety of Vilobelimab in Ulcerative Pyoderma Gangrenosum
- phase2Non-comparative Study of IFX-1 Alone or IFX-1+Pembrolizumab in Patients With Locally Advanced or Metastatic cSCC.
- phase2Exploratory Study of IFX-1 in Patients With Pyoderma Gangrenosum
News(1)
- Novo workforce down 13,000Follow along as BioSpace tracks job cuts and restructuring initiatives.biospace · 5d ago
Data sources
last refreshed 2h ago
Found something off?
comments(0)
5-min edit window · permanent after that